Achieve recognition of all radiotherapy professions
Best paper award - Interdisciplinary: Advancing the ESTRO-HERO cost tool for innovative treatment costing and flexible resource allocation
The 17th European Multidisciplinary Congress on Urological Cancers (EMUC25)
CBCT vs. MR: Which will lead the future of online adaptive radiotherapy? Positioning & Immobilisation
Factors influencing locoregional recurrence rates in rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial
Final Results of the PEACE-V STORM Trial: Elective Nodal Radiotherapy Versus Metastasis-Directed Therapy for Oligorecurrent Nodal Prostate Cancer
Topic. Radiotherapy in mutation-driven Non-small cell lung cancer (NSLC)